Board of Advisors
Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues
| Richard Bagger Former Executive Vice President, Corporate Affairs and Market Access Celgene Corporation 2012-2019 rich.bagger@comcast.net |
| Kenneth Berkowitz, Esq. Healthcare Consultant The PharMed Group Formerly Vice President, Public Affairs, Drug Regulatory and Drug Safety Affairs. Hoffmann-La Roche, Inc. kpberk77@gmail.com |
| David E.De Lorenzi, Esq. Chair, Intellectual Property Department Gibbons PC ddelorenzi@gibbonslaw.com |
| Debbie Hart President BioNJ dhart@bionj.org |
| Michael J. Lerner Chairman of the Board, Lerner Center Partner & Chair of Life Sciences Group Lowenstein Sandler LLP mlerner@lowenstein.com |
| Christopher J. Molloy University Professor, New Brunswick Rutgers University molloy@rutgers.edu |
| Joseph Pieroni Former President and CEO Daiichi Sankyo, Inc. joseph.pieroni1@gmail.com |
| Alan Rubino Former Chief Executive Officer & President RenovaCare Inc alanrubino@gmail.com |
| Cole Werble Senior Editor; Co-founder The RPM Report; Prevision Policy LLC cole.werble@previsionpolicy.com |
| Gail Wilensky Senior Fellow Project Hope gwilensky@projecthope.org |
| James Sapirstein Chairman, President, and CEO, First Wave Bio jsapirstein@firstwavebio.com |
| Dimitrios Kandylas Assistant General Counsel, US Type 1 Diabetes, Sanofi dimitrios.kandylas@sanofi.com, dkanylas@gmail.com |
| David S. Weiss Chief Strategic Officer & General Counsel, Cognivia LLC david.weiss@cognivia.com |
| Peter Marchesini Senior Vice President at Indegene petemarchesini@gmail.com |
| Cliff Neukrug Pharmaceutical Sales Leader cneukrug@gmail.com |
| Lei Lei Dean Rutgers Business School llei@business.rutgers.edu |
| Mahmud Hassan Director, Lerner Center Professor, Finance & Economics Rutgers Business School hassanm@business.rutgers.edu |